The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone

被引：0

作者：

Constance Delaby

Teresa Estellés

Nuole Zhu

Javier Arranz

Isabel Barroeta

María Carmona-Iragui

Ignacio Illán-Gala

Miguel Ángel Santos-Santos

Miren Altuna

Isabel Sala

M. Belén Sánchez-Saudinós

Laura Videla

Sílvia Valldeneu

Andrea Subirana

Mireia Tondo

Francisco Blanco-Vaca

Sylvain Lehmann

Olivia Belbin

Rafael Blesa

Juan Fortea

Alberto Lleó

Daniel Alcolea

机构：

[1] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,Sant Pau Memory Unit, Department of Neurology

[2] Universitat Autònoma de Barcelona,Servei de Bioquímica i Biologia Molecular

[3] IRMB,undefined

[4] INM,undefined

[5] Université de Montpellier,undefined

[6] INSERM,undefined

[7] CHU de Montpellier,undefined

[8] Laboratoire de Biochimie-Protéomique clinique,undefined

[9] Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas,undefined

[10] CIBERNED,undefined

[11] Fundació Catalana Síndrome de Down,undefined

[12] Centre Mèdic Down,undefined

[13] Servei de Bioquímica,undefined

[14] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,undefined

[15] Universitat Autònoma de Barcelona,undefined

[16] Unversitat Autònoma de Barcelona,undefined

[17] Centro de Investigación Biomédica en Red en Diabetes y Enfermedades Metabólicas (CIBERDEM),undefined

来源：

Alzheimer's Research & Therapy | / 14卷

关键词：

Amyloid; Aβ1–40; Aβ1–42; Cerebrospinal fluid; Tau; Biomarkers;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ1-40/Aβ1-42
Ikeda, Masaki
Hirayanagi, Kimitoshi
Arai, Motonobu
Kakuda, Satoko
Makioka, Kouki
Furuta, Natsumi
Takai, Eriko
Kasahara, Hiroo
Tsukagoshi, Setsuki
Fujita, Yukio
Amari, Masakuni
Takatama, Masamitsu
Nakazato, Yoichi
Okamoto, Koichi
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2012, 19 (04): : 186 - 190
[42] Correlation between decreased CSF α-synuclein and Aβ1-42 in Parkinson disease
Buddhala, Chandana
Campbell, Meghan C.
Perlmutter, Joel S.
Kotzbauer, Paul T.
NEUROBIOLOGY OF AGING, 2015, 36 (01) : 476 - 484
[43] Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)
Hugo Vanderstichele
Leentje Demeyer
Shorena Janelidze
Els Coart
Erik Stoops
Kimberley Mauroo
Victor Herbst
Cindy François
Oskar Hansson
Alzheimer's Research & Therapy, 9
[44] Tau protein and beta-amyloid1-42 CSF levels in different phenotypes of Parkinson's disease
Vranova, Hana Prikrylova
Mares, Jan
Hlustik, Petr
Nevrly, Martin
Stejskal, David
Zapletalova, Jana
Obereigneru, Radko
Kanovsky, Petr
JOURNAL OF NEURAL TRANSMISSION, 2012, 119 (03) : 353 - 362
[45] Amyloid beta 1-42 in cerebrospinal fluid is associated with cognitive plasticity
Uttner, Ingo
Schurig, Niklas
von Arnim, Christine A. F.
Lange-Asschenfeldt, Christian
Brettschneider, Johannes
Riepe, Matthias W.
Tumani, Hayrettin
PSYCHIATRY RESEARCH, 2011, 190 (01) : 132 - 136
[46] Stability of Plasma Amyloid-β 1-40, Amyloid-β 1-42, and Total Tau Protein over Repeated Freeze/Thaw Cycles
Liu, Huei-Chun
Chiu, Ming-Jang
Lin, Chin-Hsien
Yang, Shieh-Yueh
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2020, 10 (01) : 46 - 55
[47] CSF levels of tau, β-amyloid1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
Sjögren, M
Minthon, L
Davidsson, P
Granérus, AK
Clarberg, A
Vanderstichele, H
Vanmechelen, E
Wallin, A
Blennow, K
JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (05) : 563 - 579
[48] CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and 11C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease
Ikeda, Masaki
Tashiro, Yuichi
Takai, Eriko
Kurose, Sachiko
Fugami, Naoko
Tsuda, Kazuhisa
Arisaka, Yukiko
Kodaira, Sayaka
Fujita, Yukio
Makioka, Kouki
Mizuno, Yuji
Shimada, Hirotaka
Harigaya, Yasuo
Takatama, Masamitsu
Amari, Masakuni
Yamazaki, Tsuneo
Yamaguchi, Haruyasu
Higuchi, Tetsuya
Okamoto, Koichi
Tsushima, Yoshito
Ikeda, Yoshio
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2014, 21 (04): : 238 - 245
[49] Cerebrospinal fluid tau and amyloid β42 protein in patients with myotonic dystrophy type 1
Winblad, S.
Mansson, J. E.
Blennow, K.
Jensen, C.
Samuelsson, L.
Lindberg, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (09) : 947 - 952
[50] Role of the Aβ1-42/Aβ1-40 ratio in the concept 'Alzheimer's disease contributes to mild cognitive impairment'
Monge-Garcia, Victoria
Llorca-Tolon, Lourdes
Gasparini-Berenguer, Ruth
Monge-Argiles, Jose A.
REVISTA DE NEUROLOGIA, 2021, 72 (11) : 371 - 376

← 1 2 3 4 5 →